
BEIJING, July 8 -- China will begin regular surprise inspections on pharmaceutical and medical device firms on September 1, according to China Food and Drug Administration (CFDA) on Wednesday.
A surprise check will be initiated without early notice to the companies and law enforcement will disclose no information about the process and problems spotted during the inspection, according to the CFDA.
When all the evidence has been collected and the nature of problems determined, local CFDA units will inform the manufacturers of rectification instructions.
Surprise checks will also be launched when authorities are contacted by whistle-blowers from the public or become suspicious of certain firms, said the CFDA.
The CFDA also stipulated restrictive rules on law enforcers with the drug administration. Any one found deliberately leaking confidential information on inspections or informers will be subject to discipline. Those involved with suspected criminal acts will also be transferred to judicial departments.
Campus belle in HK goes viral online
Lugou Bridge in 78 years: July 7 incident
Get ready for the world's most thrilling water rides
Evolution of Chinese beauties in a century
Creative graduation caps of ‘vigorous elves’
Typhoon class strategic Submarine in photos
Japan’s crimes committed against "comfort women"
Legendary life of a bee-keeping master in Hainan
4-year-old cute 'monk' spends summer holiday in temple
Top 10 most competitive Chinese cities in Belt and Road Initiative
Top 10 travel destinations in the world
Can China play a role in Greek debt crisis?
Dogs in uniform: China’s combat canines
Cut for China
Market reacts to govt support Day|Week